• COVID-19
  • Biosimilars
  • Cataract Therapeutics
  • DME
  • Gene Therapy
  • Workplace
  • Ptosis
  • Optic Relief
  • Imaging
  • Geographic Atrophy
  • AMD
  • Presbyopia
  • Ocular Surface Disease
  • Practice Management
  • Pediatrics
  • Surgery
  • Therapeutics
  • Optometry
  • Retina
  • Cataract
  • Pharmacy
  • IOL
  • Dry Eye
  • Understanding Antibiotic Resistance
  • Refractive
  • Cornea
  • Glaucoma
  • OCT
  • Ocular Allergy
  • Clinical Diagnosis
  • Technology

Fifth-generation femtosecond laser receives FDA clearance

Article

Santa Ana, CA-Advanced Medical Optics (AMO) has received FDA clearance for a fifth-generation femtosecond laser (iFS).

Santa Ana, CA-Advanced Medical Optics (AMO) has received FDA clearance for a fifth-generation femtosecond laser (iFS).

Capable of creating a corneal flap during the LASIK procedure in less than 10 seconds, according to the company, the laser has an inverted bevel-in side cut angle designed to ease the flap-lifting process, increase postoperative flap adhesion, and enhance the biomechanical stability of the cornea postoperatively. When customized, it also is capable of producing an elliptical flap.

Additional features of the laser, according to the company, include a higher repetition rate; tighter spot separation; lower energy; high-resolution digital video microscope; contemporary user interface, keyboard, and touch screen; and a design meant to be ergonomic.

“The . . . laser builds upon an 8-year history of innovation and more than 2 million IntraLase femtosecond procedures performed worldwide,” said AMO Chairman and Chief Executive Officer James Mazzo, who noted that the laser is part of the company’s proprietary technology suite (iLASIK).

Perry S. Binder, MD, of the Gordon Binder Weiss Vision Institute, San Diego, said, “The new . . . laser provides the surgeon with the ability to select LASIK flap dimensions customizable to individual refractive errors and corneal anatomy.” He observed clinical trials of the laser and served as medical monitor for the technology prior to its clearance by the FDA.

The laser may be ordered now for shipment in the United States by the third quarter of this year.

Related Videos
Dr. Neda Nikpoor Shares Practical Techniques to Combat Unconscious Gender Bias and Promote Gender Equality in Ophthalmology
ASCRS 2024: George O. Waring, MD, shares early clinical performance of bilateral Odyssey implantation
ASCRS 2024: Deborah Gess Ristvedt, DO, discusses third-generation trabecular micro-bypass
Arjan Hura, MD, highlights the clinical and surgical updates at CIME 2024
© 2024 MJH Life Sciences

All rights reserved.